Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease
Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Gastrointestinal side effects, difficulty accessing therapeutic doses and poor patient compliance have been identified as barriers to effective treatment with these substances. The rivastigmine transder...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 July 2010
|
| In: |
CNS neuroscience & therapeutics
Year: 2010, Jahrgang: 16, Heft: 4, Pages: 246-253 |
| ISSN: | 1755-5949 |
| DOI: | 10.1111/j.1755-5949.2010.00141.x |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1755-5949.2010.00141.x Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1755-5949.2010.00141.x 
|
| Verfasserangaben: | Murat Emre, Roberto Bernabei, Rafael Blesa, Roger Bullock, Luis Cunha, Hugo Daniëls, Edward Dziadulewicz, Hans Förstl, Lutz Frölich, Tomasz Gabryelewicz, Oleg Levin, James Lindesay, Pablo Martínez-Lage, Andreas Monsch, Magda Tsolaki & Teus Van Laar |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1845905997 | ||
| 003 | DE-627 | ||
| 005 | 20230710132932.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230522s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1755-5949.2010.00141.x |2 doi | |
| 035 | |a (DE-627)1845905997 | ||
| 035 | |a (DE-599)KXP1845905997 | ||
| 035 | |a (OCoLC)1389794504 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Emre, Murat |e VerfasserIn |0 (DE-588)1290191115 |0 (DE-627)1845906853 |4 aut | |
| 245 | 1 | 0 | |a Drug profile |b transdermal rivastigmine patch in the treatment of Alzheimer disease |c Murat Emre, Roberto Bernabei, Rafael Blesa, Roger Bullock, Luis Cunha, Hugo Daniëls, Edward Dziadulewicz, Hans Förstl, Lutz Frölich, Tomasz Gabryelewicz, Oleg Levin, James Lindesay, Pablo Martínez-Lage, Andreas Monsch, Magda Tsolaki & Teus Van Laar |
| 264 | 1 | |c 1 July 2010 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.05.2023 | ||
| 520 | |a Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Gastrointestinal side effects, difficulty accessing therapeutic doses and poor patient compliance have been identified as barriers to effective treatment with these substances. The rivastigmine transdermal patch provides continuous delivery of drug through the skin into the bloodstream, avoiding the fluctuations in plasma concentration associated with oral administration. This pharmacokinetic profile is associated with reduced side effects, resulting in easier access to expected target doses. These benefits, along with other practical advantages of the transdermal patch, may contribute to enhanced patient compliance. Here, we present a review of the current literature on rivastigmine patch, and offer advice based on our own collective clinical experience. Rivastigmine patch provides an efficient option for managing patients with AD, to be considered among the first line therapies for the disease. | ||
| 650 | 4 | |a Alzheimer's disease | |
| 650 | 4 | |a Patch | |
| 650 | 4 | |a Rivastigmine | |
| 650 | 4 | |a Transdermal | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a Bernabei, Roberto |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blesa, Rafael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bullock, Roger |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cunha, Luis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Daniëls, Hugo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dziadulewicz, Edward |e VerfasserIn |4 aut | |
| 700 | 1 | |a Förstl, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Frölich, Lutz |d 1956- |e VerfasserIn |0 (DE-588)1028327099 |0 (DE-627)730567516 |0 (DE-576)375813160 |4 aut | |
| 700 | 1 | |a Gabryelewicz, Tomasz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Levin, Oleg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lindesay, James |e VerfasserIn |4 aut | |
| 700 | 1 | |a Martínez-Lage, Pablo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Monsch, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tsolaki, Magda |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Laar, Teus |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t CNS neuroscience & therapeutics |d Oxford : Wiley-Blackwell, 2008 |g 16(2010), 4 vom: Aug., Seite 246-253 |h Online-Ressource |w (DE-627)564758108 |w (DE-600)2423467-9 |w (DE-576)306836203 |x 1755-5949 |7 nnas |a Drug profile transdermal rivastigmine patch in the treatment of Alzheimer disease |
| 773 | 1 | 8 | |g volume:16 |g year:2010 |g number:4 |g month:08 |g pages:246-253 |g extent:8 |a Drug profile transdermal rivastigmine patch in the treatment of Alzheimer disease |
| 856 | 4 | 0 | |u https://doi.org/10.1111/j.1755-5949.2010.00141.x |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1755-5949.2010.00141.x |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230522 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1028327099 |a Frölich, Lutz |m 1028327099:Frölich, Lutz |d 60000 |e 60000PF1028327099 |k 0/60000/ |p 9 | ||
| 999 | |a KXP-PPN1845905997 |e 4324444730 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 22.05.2023"],"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"1 July 2010"}],"title":[{"title":"Drug profile","title_sort":"Drug profile","subtitle":"transdermal rivastigmine patch in the treatment of Alzheimer disease"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Murat Emre, Roberto Bernabei, Rafael Blesa, Roger Bullock, Luis Cunha, Hugo Daniëls, Edward Dziadulewicz, Hans Förstl, Lutz Frölich, Tomasz Gabryelewicz, Oleg Levin, James Lindesay, Pablo Martínez-Lage, Andreas Monsch, Magda Tsolaki & Teus Van Laar"]},"physDesc":[{"extent":"8 S."}],"recId":"1845905997","relHost":[{"recId":"564758108","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["564758108"],"doi":["10.1111/(ISSN)1755-5949"],"issn":["1755-5949"],"zdb":["2423467-9"]},"note":["Gesehen am 27.05.2020"],"origin":[{"publisherPlace":"Oxford ; Oxford","dateIssuedDisp":"2008-","dateIssuedKey":"2008","publisher":"Wiley-Blackwell ; Blackwell"}],"pubHistory":["14.2008 -"],"title":[{"title":"CNS neuroscience & therapeutics","title_sort":"CNS neuroscience & therapeutics"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Drug profile transdermal rivastigmine patch in the treatment of Alzheimer diseaseCNS neuroscience & therapeutics","language":["eng"],"part":{"text":"16(2010), 4 vom: Aug., Seite 246-253","issue":"4","pages":"246-253","year":"2010","volume":"16","extent":"8"}}],"id":{"eki":["1845905997"],"doi":["10.1111/j.1755-5949.2010.00141.x"]},"person":[{"display":"Emre, Murat","family":"Emre","role":"aut","given":"Murat"},{"display":"Bernabei, Roberto","family":"Bernabei","role":"aut","given":"Roberto"},{"family":"Blesa","display":"Blesa, Rafael","given":"Rafael","role":"aut"},{"role":"aut","given":"Roger","display":"Bullock, Roger","family":"Bullock"},{"given":"Luis","role":"aut","family":"Cunha","display":"Cunha, Luis"},{"role":"aut","given":"Hugo","family":"Daniëls","display":"Daniëls, Hugo"},{"display":"Dziadulewicz, Edward","family":"Dziadulewicz","given":"Edward","role":"aut"},{"role":"aut","given":"Hans","family":"Förstl","display":"Förstl, Hans"},{"given":"Lutz","role":"aut","display":"Frölich, Lutz","family":"Frölich"},{"given":"Tomasz","role":"aut","display":"Gabryelewicz, Tomasz","family":"Gabryelewicz"},{"role":"aut","given":"Oleg","display":"Levin, Oleg","family":"Levin"},{"display":"Lindesay, James","family":"Lindesay","role":"aut","given":"James"},{"display":"Martínez-Lage, Pablo","family":"Martínez-Lage","role":"aut","given":"Pablo"},{"role":"aut","given":"Andreas","family":"Monsch","display":"Monsch, Andreas"},{"display":"Tsolaki, Magda","family":"Tsolaki","given":"Magda","role":"aut"},{"display":"Van Laar, Teus","family":"Van Laar","role":"aut","given":"Teus"}],"language":["eng"]} | ||
| SRT | |a EMREMURATBDRUGPROFIL1201 | ||